Dragonfly Biosciences UK Expects to Commence Trading under the Symbol DRF on the Australian Securities Exchange Ltd (ASX) early January 2022 |
December 10, 2021 | December 2021 Bond Updates |
Prospectus Approved by the Australian Securities and Investments Commission LONDON, Dec. 10, 2021 /PRNewswire/ -- British Company, Dragonfly Biosciences UK, the makers of Dragonfly CBD, Europe's largest and leading, award winning seed to shelf range of CBD oils and skincare products, is... |
View more at: https://www.prnewswire.com:443/news-releases/dragonfly-biosciences-uk-expects-to-commence-trading-under-the-symbol-drf-on-the-australian-securities-exchange-ltd-asx-early-january-2022-301441901.html |